Noxafil (posaconazole delayed-release tablets [generic], oral suspension [generic], PowderMix for delayed-release oral suspension - Merck) — Cigna
Esophageal Candidiasis in a Patient with Human Immunodeficiency Virus (HIV) Infection – Chronic Suppressive Treatment
Initial criteria
- Patient has HIV infection
- Diagnosis of esophageal candidiasis requiring chronic suppressive treatment
Approval duration
6 months